Injection Port Market

Injection Port Market, By Type (Re-sealable injection ports, Self-sealing injection ports), By Application (Pharmaceuticals, Biotechnology, Medical devices, Others), By Material (Silicone, Polyisoprene, Thermoplastic elastomers (TPEs), Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

A medical gadget called an injection port offers a secure and practical entry point for the administration of fluids or drugs. For repeated injections without the need for several needle insertions, it is often a tiny, self-sealing valve or septum that can be ruptured with a needle or other medical device. Injections like the insulin are often painful and inconvenient for patients, resulting in poor adherence and glycemic control. Advanced injection methods as the i-Port Advance (Medtronic MiniMed, Northridge, Calif) provide a comfortable and dependable method for patients to inject multiple daily insulin doses without skin punctures. However, local complications can occur at the injection site, including scarring, infections, and bleeding.

Market Dynamics:

The prevalence of chronic diseases, like cancer, diabetes, and cardiovascular disease, has increased, necessitating the administration of medications, including injections, more frequently. Injection ports offer a convenient and efficient method for repetitive vein access, thereby facilitating drug administration and enhancing patient comfort.

The industry of medical devices, including injection ports, is subject to stringent regulatory requirements and standards. Compliance with these regulations, such as acquiring the necessary approvals and certifications, can be time-consuming and expensive, which can impede the market entry of new actors and impede innovation.

Key features of the study:

This report provides in-depth analysis of the global injection port market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global injection port market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include West Pharmaceutical Services, Inc., Berry Global Inc., Sartorius AG, Corning Inc., Gerresheimer AG, SCHOTT AG, Stevanato Group, AptarGroup, Inc., SGD Pharma, Ompi - Stevanato Group, DWK Life Sciences, Nipro Corporation, Nolato AB, Terumo Corporation, Qosina Corp.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global injection port market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injection port market

Detailed Segmentation:

Global Injection Port Market, By Type:

Re-sealable injection ports

Self-sealing injection ports

Global Injection Port Market, By Application:

Pharmaceuticals

Biotechnology

Medical devices

Others

Global Injection Port Market, Material:

Silicone

Polyisoprene

Thermoplastic elastomers (TPEs)

Others

Global Injection Port Market, Geography:

North America

Europe

Asia-Pacific

Middle East and Africa

Latin America

Company Profile

West Pharmaceutical Services, Inc.,

Berry Global Inc.,

Sartorius AG,

Corning Inc.,

Gerresheimer AG,

SCHOTT AG,

Stevanato Group,

AptarGroup, Inc.,

SGD Pharma,

Ompi - Stevanato Group,

DWK Life Sciences,

Nipro Corporation,

Nolato AB,

Terumo Corporation,

Qosina Corp.